SERKO LIMITED (SKO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SKO

SKO - SERKO LIMITED

FNArena Sector : Software & Services
Year End: March
GICS Industry Group : Software & Services
Debt/EBITDA: -0.49
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.50

20 Feb
2025

0.000

OPEN

$3.50

0.000

HIGH

$3.50

0

LOW

$3.50

TARGET
$5.08 45.1% upside
OTHER COMPANIES IN THE SAME SECTOR
360 . AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . GTK . KYP . NET . NXL . QOR . RDY . UBN . VGL . XF1 . YOJ . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS
SKO: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) - 8.6 xxx
DPS (cps) 0.0 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio N/A xxx
Dividend Yield 0.0% xxx
Div Pay Ratio(%) N/A xxx
This company reports in NZD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-12.1
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx63.7 M
Book Value Per Share xxxxxxxxxxxxxxx88.0
Net Operating Cash Flow xxxxxxxxxxxxxxx5.5 M
Net Profit Margin xxxxxxxxxxxxxxx-23.09 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-13.16 %
Return on Invested Capital xxxxxxxxxxxxxxx-13.00 %
Return on Assets xxxxxxxxxxxxxxx-11.73 %
Return on Equity xxxxxxxxxxxxxxx-13.16 %
Return on Total Capital xxxxxxxxxxxxxxx-17.00 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx5.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx1 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx74 M
Price To Book Value xxxxxxxxxxxxxxx4.05

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx10.6 M
Capex % of Sales xxxxxxxxxxxxxxx16.62 %
Cost of Goods Sold xxxxxxxxxxxxxxx69 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx14 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

05/12/2024

1

Outperform

-

-

Macquarie believes the acquisition of GetThere and partnerships with Booking Holdings and Sabre will boost Serko internationally, with potential upside for an earnings upgrade.

The company's software has around 70% market share in A&NZ but remains low globally. The acquisition is expected to increase market share in North America, with the partnerships providing access to established brands, customer bases, and sales teams, the analyst states.

Serko also announced a -NZ$40m accelerated investment program in addition to R&D spending of approximately -NZ$40m annually.

Macquarie raises EPS estimates by 3% for FY25 and 11% for FY26 but remains below management's FY30 revenue target by -21%.

Target price decreases to NZ$4.38 from NZ$5. Outperform rating unchanged. The company's Investor Day is scheduled for December 10.

FORECAST
Macquarie forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -12.14 cents.
Macquarie forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -7.21 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

16/12/2024

2

Overweight

-

-

Jarden observes the recent pickup in Booking.com for Business activity as supportive of higher confidence in the unmanaged travel growth path, with recent acquisitions of GetThere and a partnership with Sabre de-risking 'single customer' risk for Serko.

The company hosted an investor day where management highlighted an acceleration in activity on Booking.com for Business, with better customer interaction on the tool as it scales.

No change to the Overweight rating or NZ$4.70 target price.

FORECAST
Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -2.37 cents.
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -0.18 cents.
Access Extra Coverage Research History >

SKO STOCK CHART

FNArena News on SKO

1
Australian Broker Call *Extra* Edition – Dec 16, 2024

Dec 16 2024 - Daily Market Reports
2
FNArena Corporate Results Monitor – 09-12-2024

Dec 09 2024 - Australia
3
Australian Broker Call *Extra* Edition – Nov 01, 2024

Nov 01 2024 - Daily Market Reports
4
FNArena Corporate Results Monitor – 07-06-2024

Jun 07 2024 - Australia
5
Next Week At A Glance – 27-31 May 2024

May 24 2024 - Weekly Reports

Latest Software & Services News

1
Pro Medicus’ Valuation Predicament

Feb 19 2025 - Australia
2
DeepSeek Fuels AI Technology Advances

Feb 06 2025 - Feature Stories
3
DeepSeek & More AI Excitement For 2025

Jan 28 2025 - Feature Stories
4
Xero: The Pause That Refreshes

Jan 23 2025 - Technicals
5
Pro Medicus, A Global Software Super Star

Dec 19 2024 - Australia
6
Higher Margins Underpin Gentrack’s Ambitions

Nov 28 2024 - Small Caps
7
Targets Jump For Embattled WiseTech

Nov 28 2024 - Australia
8
Nuix Rises From The Ashes

Nov 08 2024 - Small Caps
9
WiseTech In Global Supply Chain Sweet Spot

Oct 10 2024 - Australia
10
Quality By Any Objective Measure

Oct 04 2024 - Small Caps